REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sanofi Bulgaria EOOD (Bulgaria)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sanofi Bulgaria EOOD Profile Updated: December 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Paris-based health-care company Sanofi-Aventis entered the Bulgarian market in 1995. The local unit is active in the wholesale of drugs and medical research. Sanofi-Aventis Bulgaria obtained a local licence to wholesale pharmaceutical products in August 2007.

Headquarters
90 Tsarigradsko shose Blvd., Capital Fort Business Center, Body A, fl. 10
Sofia; Sofia - city; Postal Code: 1784

Contact Details: Purchase the Sanofi Bulgaria EOOD report to view the information.

Website: http://www.sanofi-aventis.bg/

Basic Information
Total Employees:
Purchase the Sanofi Bulgaria EOOD report to view the information.
Outstanding Shares:
Purchase the Sanofi Bulgaria EOOD report to view the information.
Registered Capital:
Purchase the Sanofi Bulgaria EOOD report to view the information.
Financial Auditors:
Purchase the Sanofi Bulgaria EOOD report to view the information.
Incorporation Date:
January 31, 1994
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sanofi Bulgaria EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
4.78%▲
Total operating revenue
4.78%▲
Operating profit (EBIT)
-9.72%▼
EBITDA
-5.12%▼
Net Profit (Loss) for the Period
-28.97%▼
Total assets
-49.68%▼
Total equity
16.21%▲
Operating Profit Margin (ROS)
-0.73%▼
Net Profit Margin
-1.45%▼
Return on Equity (ROE)
-9.87%▼
Debt to Equity Ratio
-47.75%▼
Quick Ratio
1.52%▲
Cash Ratio
0.02%▲

Similar companies

Sopharma Trading AD
 
Sting AD
Pharmnet EAD
 
Alvogen Pharma Trading Europe EOOD
Huveproject EAD
 
Alta Pharmaceuticals EOOD
Fortuna Kom OOD
 
Racio Lek EOOD
Abbvie EOOD
 
Mylan EOOD
Novo Nordisk Pharma EAD
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo